文献速递关节外科

髋膝关节假体周围感染患者报告结局:纵向前瞻性观察研究

Patient-Reported Outcomes Following Periprosthetic Joint Infection of the Hip and Knee: A Longitudinal, Prospective Observational Study.
PubMed 文献 · J Bone Joint Surg Am · 2024-05-09

该前瞻性多中心观察队列纳入741例新诊断髋或膝关节假体周围感染患者,在诊断时及3、12、24个月评估牛津髋评分或牛津膝评分。12个月时髋评分从24.5改善至36、膝评分从25改善至34(p<0.0001),24个月无进一步改善;临床治愈和早期感染独立预测功能成功,而慢性肾功能损害、充血性心力衰竭和诊断时炎症临床体征独立预测功能失败。

要点

  • 12个月时牛津髋评分从24.5改善至36、牛津膝评分从25改善至34,24个月无进一步改善。
  • 临床治愈(aOR=1.88)和早期感染(aOR=2.56)独立预测功能成功。
  • 慢性肾功能损害、充血性心力衰竭和诊断时炎症临床体征独立预测功能失败。

核心结论

  • 牛津髋评分和牛津膝评分在基线和12个月时因假体周围感染类型不同而存在显著差异,强调评估治疗成功时需考虑假体周围感染类型。
  • 本研究强调早期假体周围感染和实现临床治愈与更优功能结局相关。

研究设计与样本

  • PIANO(澳大利亚和新西兰假体周围感染观察研究)队列前瞻性纳入来自多个中心的新诊断假体周围感染患者。
  • 在假体周围感染诊断时(基线)及3、12、24个月评估牛津髋评分和牛津膝评分,并根据假体周围感染类型、患者特征和管理方式分析评分及评分变化。
  • 12个月功能成功定义为牛津髋评分>38或牛津膝评分>36,和/或较基线改善分别>12或>9。

主要发现

  • 741例参与者中,12个月时有233例髋假体周围感染和342例膝假体周围感染患者可获得患者报告结局。
  • 12个月时牛津髋评分从24.5改善至36、牛津膝评分从25改善至34(p<0.0001),24个月无进一步改善。
  • 迟发性急性假体周围感染患者基线牛津髋评分中位数35(四分位距22至46)、牛津膝评分中位数30(18至41),高于早期假体周围感染(牛津髋评分19[15至29]、牛津膝评分22[16至29.5])和慢性假体周围感染(牛津髋评分23[14至34]、牛津膝评分22[14至28])。
  • 逻辑回归显示临床治愈(校正比值比[aOR]=1.88,95%置信区间[CI]=1.28至2.76,p=0.001)和早期假体周围感染(aOR=2.56,95%CI=1.64至4.07,p<0.0001)独立预测功能成功。
  • 诊断时慢性肾功能损害(aOR=0.31,95%CI=0.13至0.71,p=0.007)、充血性心力衰竭(aOR=0.41,95%CI=0.17至0.95,p=0.04)和炎症临床体征(aOR=0.53,95%CI=0.33至0.85,p=0.009)独立预测未能达到功能成功。

关键数值与推荐

  • 12个月功能成功定义为牛津髋评分>38或牛津膝评分>36,和/或较基线改善分别>12或>9。
  • 临床治愈的校正比值比为1.88(95%CI=1.28至2.76,p=0.001),早期假体周围感染的校正比值比为2.56(95%CI=1.64至4.07,p<0.0001),均独立预测功能成功。
  • 慢性肾功能损害的校正比值比为0.31(95%CI=0.13至0.71,p=0.007),充血性心力衰竭的校正比值比为0.41(95%CI=0.17至0.95,p=0.04),诊断时炎症临床体征的校正比值比为0.53(95%CI=0.33至0.85,p=0.009),均独立预测功能失败。

临床怎么用

  • 评估假体周围感染治疗成功时需考虑假体周围感染类型。
  • 早期假体周围感染和实现临床治愈与更优功能结局相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of patient-reported outcome measures (PROMs) as tools for monitoring the impact and outcomes of periprosthetic joint infection (PJI) is not well described. This study analyzed the Oxford Hip Score (OHS) or Oxford Knee Score (OKS) in a prospective observational cohort of patients with hip or knee PJI. METHODS: The PIANO (Prosthetic joint Infection in Australia and New Zealand, Observational study) cohort prospectively enrolled patients with newly diagnosed PJI from multiple centers. The OHS and OKS were evaluated at PJI diagnosis (baseline) and at 3, 12, and 24 months. Scores and score changes were examined according to PJI type, patient characteristics, and management. A successful functional outcome at 12 months was defined as an OHS of >38 or OHS of >36 and/or an improvement from baseline of >12 or >9, respectively. RESULTS: Of the 741 participants, PROMs were available at 12 months for 233 with hip and 342 with knee PJI. Significant improvements (p < 0.0001) were seen at 12 months for both the OHS (24.5 to 36) and OKS (25 to 34), with no further improvement at 24 months. Patients with late-acute PJI had a higher median baseline OHS (35; interquartile range [22 to 46]) and OKS (30 [18 to 41]) than those with early PJI (OHS: 19 [15 to 29]; OKS: 22 [16 to 29.5]) or chronic PJI (OHS: 23 [14 to 34]; OKS 22 [14 to 28]). Logistic regression showed that a clinical cure (adjusted odds ratio [aOR] = 1.88, 95% confidence interval [CI] = 1.28 to 2.76, p = 0.001) and early PJI (aOR = 2.56, 95% CI = 1.64 to 4.07, p < 0.0001) independently predicted a successful functional outcome. Chronic renal impairment (aOR = 0.31, 95% CI = 0.13 to 0.71, p = 0.007), congestive cardiac failure (aOR = 0.41, 95% CI = 0.17 to 0.95, p = 0.04), and clinical signs of inflammation (aOR = 0.53, 95% CI = 0.33 to 0.85, p = 0.009) at diagnosis independently predicted failure to achieve a successful functional outcome. CONCLUSIONS: The OHS and OKS varied significantly at baseline and 12 months according to PJI type, emphasizing the need to consider the PJI type when evaluating treatment success. This study highlights superior functional outcomes associated with early PJI and with achievement of a clinical cure. LEVEL OF EVIDENCE: Therapeutic Level II . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Manning L, Rofe A, Athan E, et al. Patient-Reported Outcomes Following Periprosthetic Joint Infection of the Hip and Knee: A Longitudinal, Prospective Observational Study. J Bone Joint Surg Am. 2024. PMID: 38723046. doi:10.2106/JBJS.23.00717

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。